ACM
KALA icon

ADAR1 Capital Management’s KALA BIO KALA Stock Holding History

ADAR1 Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.5K Hold
2,830
– – ﹤0.01% 305
2025
Q4 		$78.6K Sell
2,830
-10
-0.4% -$448 0.01% 260
2025
Q3 		$217K Sell
2,840
-157
-5% -$77.9K 0.02% 176
2025
Q2 		$713K Sell
2,997
-2,982
-50% -$582K 0.11% 99
2025
Q1 		$1.71M Buy
5,979
+1,572
+36% +$595K 0.32% 63
2024
Q4 		$1.53M Sell
4,407
-1,714
-28% -$540K 0.31% 59
2024
Q3 		$1.74M Hold
6,121
– – 0.28% 54
2024
Q2 		$2.17M Buy
+6,121
New +$2.02M 0.41% 41

Other funds holding KALA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

ADAR1 Capital Management's KALA Position: Q1 2026 in Review

ADAR1 Capital Management held its KALA BIO (KALA) position steady in Q1 2026 at 2,830 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

ADAR1 Capital Management first reported a position in KALA in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.17M in Q2 2024. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • ADAR1 Capital Management held 2,830 shares of KALA BIO worth $24.5K as of Q1 2026.
  • ADAR1 Capital Management left its KALA BIO share count unchanged in Q1 2026.
  • KALA BIO made up ﹤0.01% of ADAR1 Capital Management's portfolio in Q1 2026, its #305 holding.
  • ADAR1 Capital Management first reported a position in KALA BIO in Q2 2024 and has held it in 8 quarters since.
  • ADAR1 Capital Management's KALA BIO position peaked at $2.17M in Q2 2024.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.